MPM has collected three China drugs for its ‘best of both worlds’ strategynews2026-04-29T11:00:19+00:00April 29th, 2026|Endpoints News|
Devoted Health’s 2025 revenue slips in turbulent Medicare Advantage marketnews2026-04-28T13:00:55+00:00April 28th, 2026|Endpoints News|
Galapagos spinout Coultreon raises $125M for new take on SIK inhibitionnews2026-04-28T11:00:35+00:00April 28th, 2026|Endpoints News|
Substance use disorder biotech Tempero to close after earlier ‘serious’ safety eventnews2026-04-23T18:13:36+00:00April 23rd, 2026|Endpoints News|
Where Utah’s experiment with AI doctors is headed nextnews2026-04-21T13:00:38+00:00April 21st, 2026|Endpoints News|
Flagship’s latest startup aims to solve gene therapy’s thorniest technical challengenews2026-04-21T10:30:42+00:00April 21st, 2026|Endpoints News|
Odyssey Therapeutics will try again to IPO, this time in a warmer marketnews2026-04-20T00:54:19+00:00April 20th, 2026|Endpoints News|
Terremoto raises $108M to make an ‘earthquake’ in small molecule spacenews2026-04-15T11:30:35+00:00April 15th, 2026|Endpoints News|
Beeline Medicines emerges as Bristol Myers’ partner for shelved immunology drugsnews2026-04-15T11:00:51+00:00April 15th, 2026|Endpoints News|
Updated: Seaport and Hemab file for IPOs, as Kailera pricesnews2026-04-13T01:10:39+00:00April 13th, 2026|Endpoints News|
